Parkinson's Disease Therapeutics Market Analysis, Size, Industry Trends and Forecast, 2013 to 2019

Submitted by: Submitted by

Views: 10

Words: 878

Pages: 4

Category: Business and Industry

Date Submitted: 12/02/2015 11:30 PM

Report This Essay

Hexa Research Inc.

Industry Research,Custom Research & Consulting

Parkinson's Disease Therapeutics Market Analysis, Market

Size, Share, Regional Outlook, Industry Trends, Competitive

Strategies And Segment Forecast, 2013 To 2019

Parkinson’s disease is a progressive movement disorder caused when dopamine producing nerve cells

function irregularly. Dopamine regulates movement by sending signals to the brain and facilitates the

smooth functioning of muscles. Some of the major symptoms of Parkinson’s disease include hand, arms

or leg tremors, slow movement, problems associated with balancing and walking and stiff muscles. The

fact that this disease is progressive in nature debilitates the patient’s condition and the later symptoms

of Parkinson’s include trouble swallowing, constipation, fixed or blank expressions, dementia and

speech disabilities.

The growing global prevalence of Parkinson’s disease is the primary growth driver of the global

Parkinson’s disease therapeutics market owing to the fact the an increase in the prevalence of this

disease directly widens the target population base for market players. According to the estimates of the

WHO, the global prevalence of Parkinson’s disease was valued at over 10 million in 2012. Moreover,

estimates suggest that almost one million Americans are currently living with this disease.

Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/parkinsondisease-therapeutics-industry

Hexa Research Inc.

Industry Research,Custom Research & Consulting

Incidence rates of Parkinson’s disease increase with aging and the fact that the percentage of the

world’s population above the age of 65 years will increase from 7% in 2000 to 16% in 2050 will serve this

market as a driver. The introduction of alternative therapeutic options such as deep brain stimulation

devices and the presence of high unmet medical needs in emerging markets such as India, China and

Brazil will also have a positive impact on the market.

The...